Page last updated: 2024-09-03

hwa 138 and theophylline

hwa 138 has been researched along with theophylline in 2 studies

Compound Research Comparison

Studies
(hwa 138)
Trials
(hwa 138)
Recent Studies (post-2010)
(hwa 138)
Studies
(theophylline)
Trials
(theophylline)
Recent Studies (post-2010) (theophylline)
220020,0761,6121,383

Protein Interaction Comparison

ProteinTaxonomyhwa 138 (IC50)theophylline (IC50)
Adenosine receptor A1Bos taurus (cattle)2.43

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmid-Schönbein, GW; Wong, PM1
Alléra, A; Eisenhut, T; Endres, S; Gebert, U; Moeller, J; Schönharting, MM; Semmler, J1

Other Studies

2 other study(ies) available for hwa 138 and theophylline

ArticleYear
Attenuation of spontaneous pseudopod formation in human neutrophils by pentoxifylline.
    Cell biophysics, 1991, Volume: 18, Issue:3

    Topics: Actins; Adult; Complement C5a; Cytoplasm; Dose-Response Relationship, Drug; Endotoxins; Humans; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentoxifylline; Pseudopodia; Receptors, Purinergic; Theophylline; Time Factors

1991
Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity.
    Immunology, 1993, Volume: 78, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Pentoxifylline; Theophylline; Tumor Necrosis Factor-alpha; Xanthines

1993